Literature DB >> 8691148

Interaction of CD31 with a heterophilic counterreceptor involved in downregulation of human T cell responses.

E Prager1, R Sunder-Plassmann, C Hansmann, C Koch, W Holter, W Knapp, H Stockinger.   

Abstract

CD31 is a 130-kD glycoprotein of the immunoglobulin (Ig) superfamily expressed on the surface of endothelial cells, platelets, and several leukocyte subsets. Previous reports indicated that CD31 can mediate intercellular adhesion via both homophilic and heterophilic interaction mechanisms. Using a soluble recombinant CD31-Ig fusion protein (CD31 receptor globulin [Rg]), we demonstrate here that human CD31- T lymphocytes and CD4+CD31- T cell clones express a heterophilic CD31 ligand that is upregulated 18 h after activation. Interaction of CD31Rg with CD31- T helper cell (Th) clones was divalent cation independent but could be blocked by heparin, thus indicating that the CD31 counterreceptor on T cells can be distinguished from the ligands identified on other cell types. Moreover, a single chain protein of 120 kD was precipitated by CD31Rg from the lysates of CD31- Th clones. CD31Rg completely downregulated the proliferative response and cytokine production (interleukin-4, interferon-gamma, and tumor necrosis factor-alpha) of CD31- Th clones when the cells were maximally stimulated via immobilized CD3 monoclonal antibody. These results suggest that interaction of CD31 with a heterophilic counterreceptor on T lymphocytes can interfere with a positive regulatory pathway of T cell activation, or directly signal T cells to downregulate immune function.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8691148      PMCID: PMC2192693          DOI: 10.1084/jem.184.1.41

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  46 in total

1.  CTLA4 mediates antigen-specific apoptosis of human T cells.

Authors:  J G Gribben; G J Freeman; V A Boussiotis; P Rennert; C L Jellis; E Greenfield; M Barber; V A Restivo; X Ke; G S Gray
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-31       Impact factor: 11.205

Review 2.  Acquisition of lymphokine-producing phenotype by CD4+ T cells.

Authors:  R A Seder; W E Paul
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

3.  CTLA-4 can function as a negative regulator of T cell activation.

Authors:  T L Walunas; D J Lenschow; C Y Bakker; P S Linsley; G J Freeman; J M Green; C B Thompson; J A Bluestone
Journal:  Immunity       Date:  1994-08       Impact factor: 31.745

4.  TGF-beta 1 is a potent inducer of human effector T cells.

Authors:  A Cerwenka; D Bevec; O Majdic; W Knapp; W Holter
Journal:  J Immunol       Date:  1994-11-15       Impact factor: 5.422

5.  Organization of the gene for human platelet/endothelial cell adhesion molecule-1 shows alternatively spliced isoforms and a functionally complex cytoplasmic domain.

Authors:  N E Kirschbaum; R J Gumina; P J Newman
Journal:  Blood       Date:  1994-12-15       Impact factor: 22.113

6.  Ligation of platelet/endothelial cell adhesion molecule 1 (PECAM-1/CD31) on monocytes and neutrophils increases binding capacity of leukocyte CR3 (CD11b/CD18).

Authors:  M E Berman; W A Muller
Journal:  J Immunol       Date:  1995-01-01       Impact factor: 5.422

7.  Involvement of CD31 in lymphocyte-mediated immune responses: importance of the membrane-proximal immunoglobulin domain and identification of an inhibiting CD31 peptide.

Authors:  J L Zehnder; M Shatsky; L L Leung; E C Butcher; J L McGregor; L J Levitt
Journal:  Blood       Date:  1995-03-01       Impact factor: 22.113

Review 8.  Molecular and functional aspects of PECAM-1/CD31.

Authors:  H M DeLisser; P J Newman; S M Albelda
Journal:  Immunol Today       Date:  1994-10

9.  CD31/PECAM-1 is a ligand for alpha v beta 3 integrin involved in adhesion of leukocytes to endothelium.

Authors:  L Piali; P Hammel; C Uherek; F Bachmann; R H Gisler; D Dunon; B A Imhof
Journal:  J Cell Biol       Date:  1995-07       Impact factor: 10.539

10.  Mapping the homotypic binding sites in CD31 and the role of CD31 adhesion in the formation of interendothelial cell contacts.

Authors:  J Fawcett; C Buckley; C L Holness; I N Bird; J H Spragg; J Saunders; A Harris; D L Simmons
Journal:  J Cell Biol       Date:  1995-03       Impact factor: 10.539

View more
  18 in total

1.  PECAM-1/CD31 trans-homophilic binding at the intercellular junctions is independent of its cytoplasmic domain; evidence for heterophilic interaction with integrin alphavbeta3 in Cis.

Authors:  C W Wong; G Wiedle; C Ballestrem; B Wehrle-Haller; S Etteldorf; M Bruckner; B Engelhardt; R H Gisler; B A Imhof
Journal:  Mol Biol Cell       Date:  2000-09       Impact factor: 4.138

2.  CD44: target for antiangiogenesis therapy.

Authors:  Horace M DeLisser
Journal:  Blood       Date:  2009-12-10       Impact factor: 22.113

Review 3.  PECAM-1 isoforms, eNOS and endoglin axis in regulation of angiogenesis.

Authors:  Sunyoung Park; Christine M Sorenson; Nader Sheibani
Journal:  Clin Sci (Lond)       Date:  2015-08       Impact factor: 6.124

4.  PECAM-1 (CD31) expression modulates bleeding time in vivo.

Authors:  S Mahooti; D Graesser; S Patil; P Newman; G Duncan; T Mak; J A Madri
Journal:  Am J Pathol       Date:  2000-07       Impact factor: 4.307

5.  Involvement of endothelial PECAM-1/CD31 in angiogenesis.

Authors:  H M DeLisser; M Christofidou-Solomidou; R M Strieter; M D Burdick; C S Robinson; R S Wexler; J S Kerr; C Garlanda; J R Merwin; J A Madri; S M Albelda
Journal:  Am J Pathol       Date:  1997-09       Impact factor: 4.307

6.  Leishmania major lipophosphoglycan modulates the phenotype and inhibits migration of murine Langerhans cells.

Authors:  A Ponte-Sucre; D Heise; H Moll
Journal:  Immunology       Date:  2001-12       Impact factor: 7.397

7.  Endothelial cells expressing an inflammatory phenotype are lysed by superantigen-targeted cytotoxic T cells.

Authors:  K Riesbeck; A Billström; J Tordsson; T Brodin; K Kristensson; M Dohlsten
Journal:  Clin Diagn Lab Immunol       Date:  1998-09

8.  The role of recent thymic emigrant-regulatory T-cell (RTE-Treg) differentiation during pregnancy.

Authors:  Miriam I Wagner; Charlotte Mai; Edgar Schmitt; Karsten Mahnke; Stefan Meuer; Volker Eckstein; Anthony D Ho; Matthias Schaier; Martin Zeier; Julia Spratte; Herbert Fluhr; Andrea Steinborn
Journal:  Immunol Cell Biol       Date:  2015-04-27       Impact factor: 5.126

9.  Role of CD31/platelet endothelial cell adhesion molecule-1 expression in in vitro and in vivo growth and differentiation of human breast cancer cells.

Authors:  Luisella Righi; Silvia Deaglio; Carla Pecchioni; Armando Gregorini; Alberto L Horenstein; Gianni Bussolati; Anna Sapino; Fabio Malavasi
Journal:  Am J Pathol       Date:  2003-04       Impact factor: 4.307

10.  Ig gene-like molecule CD31 plays a nonredundant role in the regulation of T-cell immunity and tolerance.

Authors:  Liang Ma; Claudio Mauro; Georgina H Cornish; Jian-Guo Chai; David Coe; Hongmei Fu; Daniel Patton; Klaus Okkenhaug; Guido Franzoso; Julian Dyson; Sussan Nourshargh; Federica M Marelli-Berg
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-26       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.